Skip to main content
SpringerLink
Log in

Quality pharmacy services and key performance indicators in Polish NICUs: a Delphi approach

  • Research Article
  • Published:
International Journal of Clinical Pharmacy Aims and scope Submit manuscript

Abstract

Background Currently, there is no literature describing what a quality level of practice entails in Polish neonatal intensive care units (NICUs), nor are there any means of currently measuring the quality of pharmaceutical care provided to NICU patients. Objective To identify a set of essential pharmacist roles and pharmacy-relevant key performance indicators (KPI’s) suitable for Polish neonatal intensive units (NICUs). Setting Polish hospital pharmacies and NICUs. Method Using a modified Delphi technique, potential KPI’s structured along Donabedian’s domains as well as pharmacy services were presented to an expert panel of stakeholders. Two online, consecutive Delphi rounds, were completed by panellists between August and September 2017. Main outcome measure To identify the minimum level of pharmacy services that should be consistently provided to NICU patients. Results A total of 16 panellists contributed to the expert panel. Overall, consensus of 75% was reached for 23 indicators and for 28 roles. When considering pharmacy services for the NICU, the experts were found to highly value traditional pharmacy roles, such as dispensing and extemporaneous compounding, however, they were still eager for roles in the other domains, such as educational and clinical services, to be listed as essential for NICU practice. Panellists were found to positively value the list of indicators presented, and excluded only 9 out of the total list. Conclusion There is a need for future research to establish a minimum standard of practice for Polish pharmacists to encourage the progression and standardisation of hospital pharmacy services to meet the level of practice seen in NICUs worldwide.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Dooley MJ, Allen KM, Doecke CJ, Galbraith KJ, Taylor GR, Bright J, et al. A prospective multicentre study of pharmacist initiated changes to drug therapy and patient management in acute care government funded hospitals. Br J Clin Pharmacol. 2004;57(4):513–21.

    Article  PubMed  PubMed Central  Google Scholar 

  2. Gilbar P, Stefaniuk K. The role of the pharmacist in palliative care: results of a survey conducted in Australia and Canada. J Palliat Care. 2002;18(4):287–92.

    PubMed  Google Scholar 

  3. Bond CA, Raehl CL. Clinical pharmacy services, pharmacy staffing, and hospital mortality rates. Pharmacother J Hum Pharmacol Drug Therapy. 2007;27(4):481–93.

    Article  CAS  Google Scholar 

  4. Cotter S, Barber N, McKee M. Survey of clinical pharmacy services in United Kingdom National Health Service hospitals. Am J Health Syst Pharm. 1994;51(21):2676–84.

    CAS  Google Scholar 

  5. Fertleman M, Barnett N, Patel T. Improving medication management for patients: the effect of a pharmacist on post-admission ward rounds. Qual Saf Health Care. 2005;14(3):207–11.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  6. Łasocha P, Merks P, Olszewska A. Farmacja szpitalna i kliniczna w Wielkiej Brytanii (Hospital and Clinical Pharmacy in the United Kingdom). Farmacja Polska. 2013;69(9):527–30.

    Google Scholar 

  7. Pawłowska I, Pawłowski L, Kocić I, Krzyżaniak N. Clinical and conventional pharmacy services in Polish hospitals: a national survey. Int J Clin Pharm. 2016;38(2):271–9.

    Article  PubMed  PubMed Central  Google Scholar 

  8. Piecuch A, Kozłowska-Wojciechowska M, Jaszewska E, Makarewicz-Wujec M. Farmaceuta kliniczny—odpowiedź na zmieniające się potrzeby społeczne (The Clinical Pharmacist—response to societal needs). Farm Pol. 2014;70(7):395–9.

    Google Scholar 

  9. Urbańczyk K. Czym właściwie jest Farmacja kliniczna? [What is clinical pharmacy?] Opieka Farmaceutyczna. 2017. http://opieka.farm/doniesienia/czym-wlasciwie-jest-farmacja-kliniczna/. Accessed 28 Oct 2017.

  10. da Silva NMM. The impact of pharmacist participation in a multidisciplinary team on an oncology ward compared with a ward clinical pharmacy service. Eur J Hosp Pharm Sci Pract. 2012;19(2):259–60.

    Google Scholar 

  11. Koshman SL, Charrois TL, Simpson SH, McAlister FA, Tsuyuki RT. Pharmacist care of patients with heart failure: a systematic review of randomized trials. Arch Intern Med. 2008;168(7):687–94.

    Article  PubMed  Google Scholar 

  12. Viktil KK, Blix HS. The impact of clinical pharmacists on drug-related problems and clinical outcomes. Basic Clin Pharmacol Toxicol. 2008;102(3):275–80.

    Article  PubMed  CAS  Google Scholar 

  13. Krzyzaniak N, Bajorek B. Medication safety in neonatal care: a review of medication errors among neonates. Ther Adv Drug Saf. 2016;7(3):102–19.

    Article  PubMed  PubMed Central  Google Scholar 

  14. Dice J, Burckart G, Woo J, Helms R. Standardized versus pharmacist-monitored individualized parenteral nutrition in low-birth-weight infants. Am J Health Syst Pharm. 1981;38(10):1487–9.

    CAS  Google Scholar 

  15. Dunkley M. Neonatal intensive care–an Australian survey of the pharmacist’s role. Aust J Hosp Pharm. 1991;21:104–8.

    Google Scholar 

  16. Gray JE, Goldmann DA. Medication errors in the neonatal intensive care unit: special patients, unique issues. Arch Dis Child Fetal Neonatal Ed. 2004;89(6):F472–3.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  17. Simpson J, Lynch R, Grant J, Alroomi L. Reducing medication errors in the neonatal intensive care unit. Arch Dis Child Fetal Neonatal Ed. 2004;89(6):F480–2.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  18. Stavroudis TA, Miller MR, Lehmann CU. Medication errors in neonates. Clin Perinatol. 2008;35(1):141–61.

    Article  PubMed  Google Scholar 

  19. Kruk ME, Kelley E, Syed SB, Tarp F, Addison T, Akachi Y. Measuring quality of health-care services: what is known and where are the gaps? WHO: Bull World Health Organ. 2017;95:389–389A. https://doi.org/10.2471/BLT.17.195099.

    Article  Google Scholar 

  20. Banks M, Board N, Curtis I, Davis E, Dunbar N, Jorm C. Developing a safety and quality framework for Australia. Darlinghurst: Australian Commission on Safety and Quality in Health Care; 2017.

    Google Scholar 

  21. European Directorate for the Quality of Medicines and HealthCare (EDQM). Pharmaceutical Care—policies and practices for a safer, more responsible and cost-effective health system. Strasbourg: Directorate for the Quality of Medicines and HealthCare of the Council of Europe, 2012.

  22. Scobie S, Thomson R, McNeil JJ, Phillips PA. Measurement of the safety and quality of health care. Med J Aust. 2006;184(10):S51.

    PubMed  Google Scholar 

  23. Wilson S, Hauck Y, Bremner A, Finn J. Quality nursing care in Australian paediatric hospitals: a Delphi approach to identifying indicators. J Clin Nurs. 2012;21(11–12):1594–605. https://doi.org/10.1111/j.1365-2702.2011.04004.x.

    Article  PubMed  Google Scholar 

  24. Krzyzaniak N, Bajorek B. Quality use of medicines in neonatal care: a review of measures of quality used to evaluate the appropriateness and rational use of medication within the NICU. Drugs Therapy Perspect. 2016;32(9):392–402.

    Article  Google Scholar 

  25. Krzyżaniak N, Pawłowska I, Bajorek B. The role of the clinical pharmacist in the NICU: a cross-sectional survey of Australian and Polish pharmacy practice. Eur J Hosp Pharm. 2018:ejhpharm-2017-001432.

  26. Fernandes O, Gorman SK, Slavik RS, Semchuk WM, Shalansky S, Bussieres JF, et al. Development of clinical pharmacy key performance indicators for hospital pharmacists using a modified Delphi approach. Ann Pharmacother. 2015;49(6):656–69. https://doi.org/10.1177/1060028015577445.

    Article  PubMed  Google Scholar 

  27. Mullen PM. Delphi: myths and reality. J Health Organ Manag. 2003;17(1):37–52.

    Article  PubMed  Google Scholar 

  28. Christie CA, Barela E. The Delphi technique as a method for increasing inclusion in the evaluation process. Can J Program Eval. 2005;20(1):105–22.

    Google Scholar 

  29. Giannarou L, Zervas E. Using Delphi technique to build consensus in practice. Int J Bus Sci Appl Manag. 2014;9(2):66–82.

    Google Scholar 

  30. Keeney S, Hasson F, McKenna H. Consulting the oracle: ten lessons from using the Delphi technique in nursing research. J Adv Nurs. 2006;53(1):205–12.

    Article  PubMed  Google Scholar 

  31. Krzyzaniak N, Bajorek B. A global perspective of the roles of the pharmacist in the NICU. Int J Pharm Pract. 2017;25(2):107–20.

    Article  PubMed  Google Scholar 

  32. World Health Organization. Health Systems—Equity. 2017. http://www.who.int/healthsystems/topics/equity/en/. Accessed 02 Oct 2017.

  33. Smoliński D. Farmacja szpitalna wychodzi z jaskini. RynekAptek. 2016. http://www.rynekaptek.pl/wywiad/farmacja-szpitalna-wychodzi-z-jaskini,16169_2.html. Accessed 02 Oct 2017.

  34. Folli HL, Poole RL, Benitz WE, Russo JC. Medication error prevention by clinical pharmacists in two children’s hospitals. Pediatrics. 1987;79(5):718–22.

    PubMed  CAS  Google Scholar 

  35. Joint FIP/WHO guidelines on good pharmacy practice: standards for quality of pharmacy service. Geneva: World Health Organization, 2011 Contract No.: 961.

  36. Engels Y, Campbell S, Dautzenberg M, van den Hombergh P, Brinkmann H, Szécsényi J, et al. Developing a framework of, and quality indicators for, general practice management in Europe. Fam Pract. 2005;22(2):215–22.

    Article  PubMed  Google Scholar 

  37. Department of Health and Human Services, Defining Levels of Care for Victorian Newborn Services, Melbourne; Victorian Government; 2015. Available from: www.health.vic.gov.au/maternitycare. Accessed 20 Nov 2017.

  38. NICE. Specialist neonatal care quality standard. skilled and multidisciplinary staff. Manchester: NICE; 2010.

  39. BAPM. Service standards for hospitals providing neonatal care. Pharmacy. London: BAPM; 2010.

  40. Roughead L, Semple S, Rosenfeld E. Literature review: medication safety in Australia. Sydney: Australian Commission on Safety and Quality in Health Care 2013.

  41. Medication Safety in the Neonatal Intensive Care Unit, Position Statement#3060 National Association of Neonatal Nurses, Chicago. 2014. http://nann.org/uploads/About/PositionPDFS/1.4.7_Medication Safety in the NICU.pdf. Accessed 15 Feb 2016.

  42. Mikeal RL, Brown TR, Lazarus HL, Vinson MC. Quality of pharmaceutical care in hospitals. Am J Health Syst Pharm. 1975;32(6):567–74.

    CAS  Google Scholar 

  43. WHO. Making pregnancy safer; assessment tool for the quality of hospital care for mothers and newborn babies. Advanced newborn care (for intensive care units). Copenhagen: WHO; 2009.

  44. Clinical Pharmacist Intensive Care (PCICU, PICU, ED and NICU)—Pharmacy. Sidra Medical and Research Center. 2015. http://www.bayt.com/en/job/clinical-pharmacist-intensive-care-pcicu-picu-ed-and-nicu-pharmacy-in-qatar-50043520/. Accessed 04 Mar 2015.

  45. Lucas AJ. Improving medication safety in a neonatal intensive care unit. Am J Health Syst Pharm. 2004;61(1):33–7.

    PubMed  Google Scholar 

  46. Simons SL. Designing medication safety in the NICU. Neonatal Netw. 2007;26(6):407–8.

    Article  PubMed  Google Scholar 

  47. Position Description: NICU Clinical Pharmacist Specialist. University of Kentucky Hospital 2009. http://www.hosp.uky.edu/pharmacy/departpolicy/PH14-45.pdf. 04 Mar 2007.

  48. Cousins D KN, Walser S,. Pharmaceutical care: policies and practices for a safer, more responsible and cost effective health system. Strasbourg: Directorate for the Quality of Medicines & HealthCare of the Council of Europe, 2012.

  49. Kunac DL, Reith DM. Identification of priorities for medication safety in neonatal intensive care. Drug Saf. 2005;28(3):251–61.

    Article  PubMed  Google Scholar 

  50. Chedoe I, Molendijk HA, Dittrich ST, Jansman FG, Harting JW, Brouwers JR, et al. Incidence and nature of medication errors in neonatal intensive care with strategies to improve safety. Drug Saf. 2007;30(6):503–13.

    Article  PubMed  Google Scholar 

  51. Ng J, Harrison J. Key performance indicators for clinical pharmacy services in New Zealand public hospitals: stakeholder perspectives. J Pharm Health Serv Res. 2010;1(2):75–84.

    Article  Google Scholar 

  52. Patel SJ, Saiman L. Principles and strategies of antimicrobial stewardship in the neonatal intensive care unit. Sem Perinatol. 2012;36(6):431–6.

    Article  Google Scholar 

  53. Sharek PJ, Powers R, Koehn A, Anand KJ. Evaluation and development of potentially better practices to improve pain management of neonates. Pediatrics. 2006;118(Supplement 2):S78–86.

    Article  PubMed  Google Scholar 

  54. Chawla D, Suresh GK. Quality improvement in neonatal care—a new paradigm for developing countries. Indian J Pediatr. 2014;81(12):1367–72.

    Article  PubMed  Google Scholar 

  55. Elverson CA, Samra HA. Overview of structure, process, and outcome indicators of quality in neonatal care. Newborn Infant Nurs Rev. 2012;12(3):154–61.

    Article  Google Scholar 

Download references

Acknowledgements

The authors would like to express their sincere gratitude to all of the experts in Poland who participated in this research.

Author information

Authors and Affiliations

  1. Graduate School of Health (Pharmacy), University of Technology Sydney, PO Box 123, Broadway, Ultimo, NSW, 2007, Australia

    Natalia Krzyżaniak & Beata Bajorek

  2. Department of Pharmacology, Medical University of Gdansk, Dębowa Str. 23, 80-204, Gdańsk, Poland

    Iga Pawłowska

Authors
  1. Natalia Krzyżaniak
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Iga Pawłowska
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Beata Bajorek
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Natalia Krzyżaniak.

Ethics declarations

Funding

None

Conflicts of interest

The authors declare no conflicts of interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Krzyżaniak, N., Pawłowska, I. & Bajorek, B. Quality pharmacy services and key performance indicators in Polish NICUs: a Delphi approach. Int J Clin Pharm 40, 533–542 (2018). https://doi.org/10.1007/s11096-018-0623-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11096-018-0623-y

Keywords

Search

Navigation